COMMUNIQUÉS West-GlobeNewswire

Adamas to Announce First Quarter 2019 Financial Results and Host Conference Call on May 9, 2019
02/05/2019
EMERYVILLE, Calif., May 02, 2019 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the company will report 2019 first quarter financial results on Thursday, May 9, 2019, after market [...]
Novavax Reports First Quarter 2019 Financial Results
02/05/2019
Company to Host Conference Call Today at 4:30 p.m. ET GAITHERSBURG, Md., May 02, 2019 (GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq: NVAX) today announced its financial results and operational highlights for the first [...]
Alder BioPharmaceuticals® Reports First Quarter 2019 Financial and Operating Results
02/05/2019
- FDA sets eptinezumab PDUFA date of February 21, 2020; launch expected in first quarter of 2020 - - Acute study planned for potential eptinezumab label expansion - - Conference call today at 5:00 p.m. ET - BOTHELL, [...]
Emergent BioSolutions Reports First Quarter 2019 Financial Results
02/05/2019
Reaffirms full year 2019 financial forecast and operational goals Provides Q2 2019 revenue forecast of $200M-$220M GAITHERSBURG, Md., May 02, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) reported [...]
Assembly Biosciences Announces Changes to Senior Leadership Team
02/05/2019
SAN FRANCISCO, May 02, 2019 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV) and diseases [...]
Leading Cancer Center in Japan Selects Hyperion Imaging System to Expand Immuno-Oncology Research Studies in Colorectal Cancer
02/05/2019
SOUTH SAN FRANCISCO, Calif., May 02, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) announced today that the Group for Innovative Cancer Treatment Division of the National Cancer Center in Japan has [...]
T2 Biosystems Reports First Quarter 2019 Financial Results and Provides Corporate Update
02/05/2019
Exceeds Q1 Guidance with Delivery of $1.8 Million in Revenue and 11 New Instrument Contracts Confirms 2019 Guidance of a Doubling of Revenue and Securing 70 – 80 T2Dx Instrument Contracts LEXINGTON, Mass., May 02, 2019 [...]
Harvard Bioscience Reports First Quarter 2019 Financial Results
02/05/2019
Reports both GAAP and adjusted non-GAAP revenue of $28.2 million, an increase of 5% and 2%, respectively HOLLISTON, Mass., May 02, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO), or the Company, a [...]
Chimerix to Announce First Quarter 2019 Financial Results on May 9, 2019
02/05/2019
DURHAM, N.C., May 02, 2019 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq: CMRX), a biopharmaceutical company developing novel antivirals to address life-threatening viral infections, today announced that it will host a [...]
Diversicare Announces 2019 First Quarter Results
02/05/2019
BRENTWOOD, Tenn., May 02, 2019 (GLOBE NEWSWIRE) -- Diversicare Healthcare Services, Inc. (NASDAQ: DVCR), a premier provider of long-term care services, today announced its results for the first quarter ended March 31, [...]
Misonix, Inc. Enters Into Definitive Agreement to Acquire Regenerative Medical Company Solsys Medical for Approximately $97 Million
02/05/2019
Transaction Creates Medical Device Company with Comprehensive Portfolio of Wound Care Solutions to Improve Healthcare Outcomes Combined Entity to Generate Over $80 Million in Annual Revenue for Fiscal 2020 FARMINGDALE, [...]
Allscripts announces first quarter 2019 results
02/05/2019
Record first quarter bookings of $286 million up 9% from the prior year period GAAP EPS ($0.04); 7% year over year growth in non-GAAP diluted EPS to $0.16 Repurchased $65 million of stock in the first quarter CHICAGO, [...]
ERYTECH to Host on May 7, 2019 First Quarter Conference Call and Business Update
02/05/2019
LYON, France, May 02, 2019 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug [...]
ERYTECH tiendra un webcast le 7 mai 2019 à l’occasion de ses résultats du premier trimestre 2019
02/05/2019
LYON, France, 02 mai 2019 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris et Nasdaq : ERYP), société biopharmaceutique de stade clinique qui développe des thérapies innovantes en encapsulant des médicaments dans les [...]
Repligen to Report First Quarter 2019 Financial Results
02/05/2019
Webcast and Conference Call to Be Held Thursday, May 9, 2019 at 8:30 a.m. EDT WALTHAM, Mass., May 02, 2019 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its first [...]
Teligent, Inc. to Hold Conference Call for First Quarter 2019 Results on Monday May 6th, 2019
02/05/2019
BUENA, N.J., May 02, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, announced the Company will hold a conference call at 4:30pm ET on Monday May 6 th [...]
Biocartis Group NV: BIOCARTIS ANNOUNCES FINAL TERMS OF ITS EUR 150 MILLION SENIOR UNSECURED CONVERTIBLE BONDS DUE 9 MAY 2024
02/05/2019
PRESS RELEASE : REGULATED INFORMATION - INSIDE INFORMATION 2 May 2019, 19:30 CEST BIOCARTIS ANNOUNCES FINAL TERMS OF ITS EUR 150 MILLION SENIOR UNSECURED CONVERTIBLE BONDS DUE 9 MAY 2024 Mechelen, Belgium, 2 May 2019 - [...]
XBiotech annonce l'achèvement du recrutement et des résultats positifs pour le bermekimab dans une étude sur le cancer pancréatique
02/05/2019
XBiotech et le Centre médical Cedars-Sinai évaluent le bermekimab en combinaison avec la chimiothérapie chez des patients atteints du cancer pancréatique et de cachexie AUSTIN, Texas, 02 mai 2019 (GLOBE NEWSWIRE) -- [...]
Agios Announces FDA Approval of Supplemental New Drug Application (sNDA) for TIBSOVO® as Monotherapy for Newly Diagnosed Adult Patients with IDH1 Mutant Acute Myeloid Leukemia (AML) Not Eligible for Intensive Chemotherapy
02/05/2019
– TIBSOVO ® is the First and Only Therapy Approved for Newly Diagnosed AML Patients with an IDH1 Mutation who are Ineligible for Intensive Chemotherapy – – sNDA Approval Based on 28 Newly Diagnosed Patients from Phase 1 [...]

Pages